Accumulating study suggested that the induction of SIGMAR1 expression exhibited outstanding neuroprotective effects in Parkinson’s disease and Alzheimer’s disease [43–45]. Here, SIGMAR1 is linked to early-onset autosomal dominant Alzheimer disease.